Biocon Limited (BIOCON) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BIOCON Analyst Ratings

Moderate Buy

1 Buy

1 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Biocon

Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BIOCON Stock 12 Month Forecast

Average Price Target

₹377.50

▲(8.92%Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Biocon Limited in the last 3 months. The average price target is ₹377.50 with a high forecast of ₹430.00 and a low forecast of ₹325.00. The average price target represents a 8.92% change from the last price of ₹346.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"301":"₹301","366":"₹366","431":"₹431","333.5":"₹333.5","398.5":"₹398.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":430,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹430.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":377.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹377.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹325.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[301,333.5,366,398.5,431],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,321.7,330.03076923076924,338.36153846153843,346.6923076923077,355.0230769230769,363.3538461538461,371.68461538461537,380.0153846153846,388.3461538461538,396.67692307692306,405.0076923076923,413.3384615384615,421.66923076923075,{"y":430,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,321.7,325.9923076923077,330.2846153846154,334.5769230769231,338.86923076923074,343.16153846153844,347.45384615384614,351.74615384615385,356.03846153846155,360.33076923076925,364.62307692307695,368.9153846153846,373.2076923076923,{"y":377.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,321.7,321.95384615384614,322.2076923076923,322.46153846153845,322.7153846153846,322.96923076923076,323.2230769230769,323.4769230769231,323.7307692307692,323.9846153846154,324.23846153846154,324.4923076923077,324.74615384615385,{"y":325,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":308.87,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":357.05,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":354.65,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":363.2,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":370.4,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":316.15,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":316.15,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":375.6,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":368.8,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":362.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.6,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":339.15,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.7,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹430.00

Average Price Target₹377.50

Lowest Price Target₹325.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shyam SrinivasanGoldman Sachs

Goldman Sachs

₹325

Hold

-6.23%

Downside

Reiterated

04/18/25

Goldman Sachs Reiterates Neutral Rating on Biocon Ltd (BIOS:IN)Goldman Sachs analyst Shyam Srinivasan reiterated a Neutral rating and INR325.00 price target on Biocon Ltd (BIOS:IN).

Damayanti KeraiHSBC

HSBC

₹430

Buy

24.06%

Upside

Reiterated

03/21/25

HSBC Reiterates Buy Rating on Biocon Ltd (BIOS:IN)HSBC analyst Damayanti Kerai reiterated a Buy rating and INR430.00 price target on Biocon Ltd (BIOS:IN).

Vivek Agrawal CFACiti

Citi

₹365→₹430

Buy

24.06%

Upside

Reiterated

02/03/25

Biocon Ltd (BIOS:IN) PT Raised to INR430 at CitiCiti analyst Vivek Agrawal raised the price target on Biocon Ltd (BIOS:IN) to INR430.00 (from INR365.00) while maintaining a Buy rating.

Alok DalalJefferies

Jefferies

₹280→₹400

Hold

15.41%

Upside

Upgraded

01/06/25

Jefferies Upgrades Biocon Ltd (BIOS:IN) to HoldJefferies analyst Alok Dalal upgraded Biocon Ltd (BIOS:IN) from Underperform to Hold with a price target of INR400.00 (from INR280.00).

Alankar GarudeKotak Mahindra

Kotak Mahindra

₹315

Sell

-9.12%

Downside

Reiterated

12/27/24

Kotak Reiterates Reduce (3) Rating on Biocon Ltd (BIOS:IN)Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR315.00 price target on Biocon Ltd (BIOS:IN).

Unknown AnalystGeojit Research

Not Ranked

Geojit Research

₹325→₹376

Hold

8.48%

Upside

Reiterated

11/20/24

Therefore, we reiterate our Accumulate rating on the stock with a revised target price of Rs. 376 based on 33x FY26E adjusted EPS.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shyam SrinivasanGoldman Sachs

Goldman Sachs

₹325

Hold

-6.23%

Downside

Reiterated

04/18/25

Goldman Sachs Reiterates Neutral Rating on Biocon Ltd (BIOS:IN)Goldman Sachs analyst Shyam Srinivasan reiterated a Neutral rating and INR325.00 price target on Biocon Ltd (BIOS:IN).

Damayanti KeraiHSBC

HSBC

₹430

Buy

24.06%

Upside

Reiterated

03/21/25

HSBC Reiterates Buy Rating on Biocon Ltd (BIOS:IN)HSBC analyst Damayanti Kerai reiterated a Buy rating and INR430.00 price target on Biocon Ltd (BIOS:IN).

Vivek Agrawal CFACiti

Citi

₹365→₹430

Buy

24.06%

Upside

Reiterated

02/03/25

Biocon Ltd (BIOS:IN) PT Raised to INR430 at CitiCiti analyst Vivek Agrawal raised the price target on Biocon Ltd (BIOS:IN) to INR430.00 (from INR365.00) while maintaining a Buy rating.

Alok DalalJefferies

Jefferies

₹280→₹400

Hold

15.41%

Upside

Upgraded

01/06/25

Jefferies Upgrades Biocon Ltd (BIOS:IN) to HoldJefferies analyst Alok Dalal upgraded Biocon Ltd (BIOS:IN) from Underperform to Hold with a price target of INR400.00 (from INR280.00).

Alankar GarudeKotak Mahindra

Kotak Mahindra

₹315

Sell

-9.12%

Downside

Reiterated

12/27/24

Kotak Reiterates Reduce (3) Rating on Biocon Ltd (BIOS:IN)Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR315.00 price target on Biocon Ltd (BIOS:IN).

Unknown AnalystGeojit Research

Not Ranked

Geojit Research

₹325→₹376

Hold

8.48%

Upside

Reiterated

11/20/24

Therefore, we reiterate our Accumulate rating on the stock with a revised target price of Rs. 376 based on 33x FY26E adjusted EPS.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biocon Limited

1 Month

xxx

Success Rate

0/2 ratings generated profit

Average Return

-2.40%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -2.40% per trade.

3 Months

xxx

Success Rate

1/2 ratings generated profit

Average Return

-5.10%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -5.10% per trade.

1 Year

Damayanti KeraiHSBC

Success Rate

1/2 ratings generated profit

Average Return

+0.40%

reiterated a buy rating 3 months ago

Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.40% per trade.

2 Years

xxx

Success Rate

1/2 ratings generated profit

Average Return

+0.10%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.10% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BIOCON Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BIOCON has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. BIOCON average Analyst price target in the past 3 months is 377.50.

Each month's total comprises the sum of three months' worth of ratings.

BIOCON Financial Forecast

BIOCON Earnings Forecast

Next quarter’s earnings estimate for BIOCON is ₹0.47 with a range of ₹0.47 to ₹0.47. The previous quarter’s EPS was ₹2.81. BIOCON beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.02% of the time in the same period. In the last calendar year BIOCON has Outperformed its overall industry.

BIOCON Sales Forecast

Next quarter’s sales forecast for BIOCON is ₹38.89B with a range of ₹38.89B to ₹38.89B. The previous quarter’s sales results were ₹44.17B. BIOCON beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.59% of the time in the same period. In the last calendar year BIOCON has Outperformed its overall industry.

BIOCON Stock Forecast FAQ

What is IN:BIOCON’s average 12-month price target, according to analysts?

Based on analyst ratings, Biocon Limited’s 12-month average price target is 377.50.

What is IN:BIOCON’s upside potential, based on the analysts’ average price target?

Biocon Limited has 8.92% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Biocon Limited a Buy, Sell or Hold?

Biocon Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.

What is Biocon Limited’s share price target?

The average share price target for Biocon Limited is 377.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹430.00 ,and the lowest forecast is ₹325.00. The average share price target represents 8.92% Increase from the current price of ₹346.6.

What do analysts say about Biocon Limited?

Biocon Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of Biocon Limited?

To buy shares of IN:BIOCON, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Biocon Limited (BIOCON) Stock Forecast & Price Target

BIOCON Analyst Ratings

BIOCON Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Biocon Limited

BIOCON Analyst Recommendation Trends

BIOCON Financial Forecast

BIOCON Earnings Forecast

BIOCON Sales Forecast

BIOCON Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts